Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling

BACKGROUND: Thirty to forty percent of patients with Diffuse Large B-cell Lymphoma (DLBCL) have an adverse clinical evolution. The increased understanding of DLBCL biology has shed light on the clinical evolution of this pathology, leading to the discovery of prognostic factors based on gene express...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosquera Orgueira, Adrián, Díaz Arias, José Ángel, Cid López, Miguel, Peleteiro Raíndo, Andrés, Antelo Rodríguez, Beatriz, Aliste Santos, Carlos, Alonso Vence, Natalia, Bendaña López, Ángeles, Abuín Blanco, Aitor, Bao Pérez, Laura, González Pérez, Marta Sonia, Pérez Encinas, Manuel Mateo, Fraga Rodríguez, Máximo Francisco, Bello López, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579992/
https://www.ncbi.nlm.nih.gov/pubmed/33087075
http://dx.doi.org/10.1186/s12885-020-07492-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579992/
https://www.ncbi.nlm.nih.gov/pubmed/33087075
http://dx.doi.org/10.1186/s12885-020-07492-y

Ejemplares similares